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Abstract The tumor promoter phorbol 12-myristate 13-acetate 
(PMA) and hormonal activators of protein kinase C (PKC) com- 
monly stimulate phospholipase D (PLD)-mediated formation of 
phosphatidic acid from phosphatidylcholine (PtdCho) in fibro- 
blasts and other cell types. On the basis that phosphatidic acid 
is a mitogen, PLD is often considered to have a major role in the 
regulation of cell growth by PKC activators. However, we found 
that in NIH 3T3 fibroblasts wortmannin, an inhibitor of 
phosphatidylinositol 3-kinase (PI3K), strongly inhibited DNA 
synthesis induced by I00 nM PMA, while it actually enhanced 
PMA-stimulated PtdCho hydrolysis. These results indicate that 
stimulation of PLD activity is either not required or not sufficient 
for the mitogenic action of PMA. 
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I. Introduction 
Phospholipase D (PLD)-mediated hydrolysis of phosphati- 
dylcholine (PtdCho) produces phosphatidic acid (PtdOH) [1,2], 
a potent mitogen i several cell types, including fibroblasts 
[2-8]. Furthermore, PtdOH can be degraded to 1,2-diacylglyc- 
erol which activates protein kinase C (PKC), an important 
regulator of cell growth [9]. For these reasons, PLD could play 
some role in the regulation of cell growth by the PKC system 
[10]. However, this question is difficult to study because the 
mechanism of mitogenic action of PMA is unknown, and no 
specific inhibitor of PLD is presently available. 
In N IH 3T3 fibroblasts, the PKC system is clearly a major 
regulator of PLD. In this system, both the tumor promoter 
phorbol 12-myristate 13-acetate (PMA) and hormonal activa- 
tors of PKC can greatly enhance PLD activity for which 
PtdCho serves as a major, although not the only, substrate 
[11,12]. Earlier, we demonstrated that the stimulatory action of 
PMA on phospholipid hydrolysis in these cells is accompanied 
by significant elevation of cellular levels of PtdOH [13]. The 
initial aim of this work was to determine whether PtdOH is a 
mediator of the mitogenic effect of PMA. For this purpose, we 
first searched for an inhibitor of PMA-induced DNA synthesis. 
Surprisingly, during this search we found, as reported here, that 
the phosphatidylinositol 3-kinase (PI3K) inhibitor wortmannin 
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[14,15] strongly inhibited PMA-induced DNA synthesis, but it 
had no such inhibitory effect on PMA-stimulated PtdCho hy- 
drolysis. 
2. Experimental 
2.1. Materials 
PMA, wortmannin and Dowex-50W (H ÷ form) were purchased from 
Sigma; [methyl-14C]choline chloride (50 mCi/mmol), [1J4C]palmitic 
acid (60 mCi/mmol) and [methyl-3H]thymidine (85 mCi/mmol) were 
bought from Amersham; phosphatidylethanol (PtdEtOH) was from 
Avanti Polar Lipids, Inc; and tissue culture reagents were purchased 
from GIBCO BRL. 
2.2. Cell culture 
NIH 3T3 clone-7 fibroblasts, kindly provided by Dr. Douglas R. 
Lowy (National Cancer Institute, NIH, Bethesda, MD), were cultured 
in Dulbecco's modified Eagle's medium supplemented with 10% fetal 
calf serum, penicillin-streptomycin (50 U/ml and 50 ¢tg/ml, respectively) 
and glutamine (2 mM). 
2.3. Labeling of cellular DNA with [3H]thymidine 
NIH 3T3 fibroblasts were grown in 12-well tissue culture dishes to 
~ 3040% confluency in the presence of 10% serum, followed by incuba- 
tion of fibroblasts in serum-free medium for 24 h. Subsequently, fibro- 
blasts were treated (in serum-free medium) first with wortmannin for 
20 min, and then with PMA and/or wortmannin for 16 h. Finally, 
incubations were continued in the presence of [methyl-3H]thymidine 
(1 ¢tCi/well) for 60 min. Fibroblasts were washed twice with phosphate- 
buffered saline and then four times with 5% trichloroacetic a id. The 
acid- insoluble material was redissolved in 0.3 M sodium hydroxide, 
and an aliquot was taken to measure DNA-associated 3H activity in a 
liquid scintillation counter. 
2.4. Measurement of PtdEtOH formation in NIH 3T3 fibroblasts 
Fibroblasts were grown in 12-well tissue culture dishes for 48 h to 
~ 80% confluency and labeled with [1-14C]palmitic a id (0.5/ICi/ml) for 
the last 24 h. Fibroblasts were washed, incubated in fresh medium for 
an additional 2-h period (to lower the amount of unesterified labeled 
palmitic acid) and then treated first with 3 ¢tM wortmannin for 20 min, 
and then with 100 nM PMA and/or wortmannin for an additional 
20-min period in the presence of 200 mM ethanol. Incubations were 
terminated by scraping the cells into 2 ml of ice-cold methanol, followed 
by rapid transfer of the methanol extract o 2 ml of chloroform. PtdE- 
tOH was separated from other phospholipids on potassium oxalate 
(1%)-impregnated Silica Gel H plates (Analtech) with a solvent system 
of chloroform/methanol/acetone/acetic acid/water (50:10:15:10:2, v/v/v/ 
v/v). 
2.5. Determination of PtdCho hydrolysis in NIH 3T3 fibroblasts 
Fibroblasts were seeded in 150 mm-diameter plastic dishes and were 
incubated with [methyl-J4C]choline (0.35 ¢tCi/ml) for 48 h. Cells were 
washed and then incubated in the corresponding fresh medium for 3 
h; this step reduces the cellular level of [14C]choline, also a product of 
PLD action, by a factor of 3~-fold. Cells were harvested by gentle 
scraping from 3-6 dishes and washed; this 15rocedure further educes 
the background level of [14C]choline, but washed cells retain sensitivity 
to PMA. Suspended cells were first treated with wortmannin for 20 min, 
then incubations were continued for 30 min in the absence or presence 
of 10-100 nM PMA and/or wortmannin. Separation of [~4C]choline 
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from other products was performed on Dowex-50W(H+)-packed col- 
umns as previously described [16]. 
3. Results and discussion 
Treatment of N IH 3T3 fibroblasts with 100 nM PMA for 16 
h in serum-free medium resulted in -23-fold increase in DNA 
synthesis (Fig. 1). Fifty nM and 3/ IM concentrations of wort- 
mannin inhibited PMA-induced DNA synthesis by ~75 and 
86%, respectively (Fig. 1). It should be emphasized that maxi- 
mal inhibitory effects of wortmannin required addition of the 
drug - 10-20 min prior to PMA. When wortmannin and PMA 
were added to the wells simultaneously, even 3/tM wortmannin 
failed to exert any effect on PMA-stimulated incorporation of 
[3H]thymidine into DNA (data not shown). 
Treatment of serum-starved fibroblasts with 10% serum for 
16 h enhanced DNA synthesis ~ 85-fold; wortmannin at both 50 
nM and 3 pM concentrations failed to significantly decrease 
serum-induced DNA synthesis (data not shown). These obser- 
vations indicated that inhibition of PMA-induced DNA synthe- 
sis was not due to some non-specific toxicity of wortmannin. 
On the other hand, 50 nM and 3/,tM concentrations of wort- 
mannin inhibited the stimulatory effect (-35-fold) of platelet- 
derived growth factor (50 ng/ml) oa DNA synthesis by 73 and 
88%, respectively (data not shown). Thus, wortmannin exhibits 
very similar inhibitory effects on PMA- and platelet-derived 
growth factor-induced DNA synthesis. 
Synthesis of phosphatidylalcohol from phospholipids and 
alcohol is a specific function of activated PLD [1,2]. Presently, 
addition of 100 nM PMA to [t4C]palmitic acid-labeled N IH  3T3 
fibroblasts enhanced the synthesis of phosphatidylethanol 
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Fig. I. Inhibition of PMA-induced DNA synthesis by wortmannin in 
NIH 3T3 fibroblasts. Serum-starved fibroblasts were incubated for 16 
h in the absence (I) or presence (II) of 100 nM PMA; there was either 
no further addition (G), or fibroblasts were additionally treated with 
0.05/IM ( ~ ), 0.2/~M ( ~ ) or 3 ruM (l) concentrations of wortman- 
nin; when present, wortmannin was added 20 min prior to PMA. Data 
represent the mean + S.E. of three experiments performed on the same 
day. Similar results were obtained in three other experiments, each 
performed in triplicate. 
, - ,  25 
( , , -  
.B  
E 
o 
" "  20 "!- "0 
0 "~- 
13" ~ 15 
I J_ o 5 
E Q. "o 
" "  0 
Fig. 2. Combined effects of PMA and wortmannin on PtdEtOH forma- 
tion. Attached NIH 3T3 fibroblasts were prelabeled with [~4C]palmitic 
acid, and then incubated for 20 min in the absence (D) or presence of 
3 pM wortmannin (vz~), 100 nM PMA (~) ,  or wortmannin +PMA 
(m). When present, wortmannin was added 20 min prior to PMA. Data 
represent the mean + S.E. of four incubations performed on the same 
day with the same passage of cells. Similar results were obtained in 
another experiment performed in triplicate. 
(PtdEtOH) ~ 3.6-fold (Fig. 2). Even a high concentration (3pM)  
of wortmannin failed to inhibit, in fact it appeared to slightly 
enhance, PMA-induced formation of PtdEtOH (Fig. 2). 
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Fig. 3. Concentration-dependent effect of wortmannin on PtdCho hy- 
drolysis. NIH 3T3 fibroblasts were labeled with [t4C]choline for 48 h, 
followed by pretreatment of suspended cells for 20 min with 0.1-3/zM 
concentrations of wortmannin. Then fibroblasts were incubated (with- 
out removing wortmannin) for a 30-min period in the absence (e) or 
presence of 10 nM PMA (A) or 100 nM PMA (m). Each point represents 
the mean +_ S.E. of four independent incubations. Similar results were 
obtained in two other experiments, each performed in triplicate. 
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In [14C]choline-labeled NIH 3T3 fibroblasts, PMA-induced 
loss of [14C]PtdCho ccurs by a PLD-mediated hydrolytic proc- 
ess [10]. In these fibroblasts, 0.1 3.0 ¢tM concentrations of 
wortmannin again tended to enhance, rather than decrease, 
PMA-induced hydrolysis of [14C]PtdCho when PMA was 
added at a maximally effective concentration (100 nM) (Fig. 3). 
We should add here that this large stimulatory effect of 100 nM 
PMA was sustained for ~ 3 h, while the slight potentiating effect 
of wortmannin became progressively less pronounced after 30 
rain incubation. However, even after a treatment for 3 h, wort- 
mannin still had a potentiating, rather than an inhibitory, effect 
on PMA (100 nM)-induced PtdCho hydrolysis (data not 
shown). At a 10 nM concentration f PMA, wortmannin had 
no potentiating effect on PtdCho hydrolysis (Fig. 3). 
It is possible that chronic (16 h) treatment of fibroblasts with 
PMA in the absence of serum results in the activation of PLD 
by a different mechanism which might be inhibited by wort- 
mannin. We examined this possibility in the following way. 
NIH 3T3 fibroblasts were labeled with [14C]Cho for 60 h and 
treated with 100 nM PMA in the absence or presence of 3 #M 
wortmannin (wortmannin being added to the cells 20 min prior 
to PMA) for the last 16 h of the labeling period. To facilitate 
comparison of this experiment with that described in Fig. l, 
treatments of attached fibroblasts with PMA were performed 
in serum-free medium. When the washed untreated and PMA- 
treated attached fibroblasts were compared, the latter exhibited 
1.5-1.6-fold increase in [14C]PtdCho hydrolysis; the co-pres- 
ence of wortmannin during the entire treatment period failed 
to prevent his small stimulatory effect of PMA (data not 
shown). 
In summary, we showed here that in NIH 3T3 fibroblasts 
wortmannin inhibits PMA-induced DNA synthesis but not 
PMA-stimulated PtdCho hydrolysis. Accordingly, in these cells 
activation of PLD is either not required or not sufficient for the 
stimulatory effect of PMA on DNA synthesis. The results also 
suggest that PI3K may be required for the mitogenic action of 
PMA; however, this possibility remains to be proven. 
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